Chronic Daily Headaches in Children
Published Online: Tuesday, March 22, 2011
Watch as Kenneth Mack, MD, PhD, a pediatric neurologist at the Mayo Clinic, describes the symptoms, diagnosis, and treatment options for chronic daily headaches in children.
The FDA has granted approval to Genzyme’s eliglustat (Cerdelga), the only first-line oral therapy for patients with Type 1 Gaucher disease.
Grocery store chain joins growing list of major companies offering enhanced specialty pharmacy.